Abstract: A siphonic toilet including a bowl, a passageway and a valve. The passageway includes an entrance fluidly connected to the bowl, an outlet, and a dam located between the entrance and the outlet, wherein the dam and bowl are configured to hold a first volume of water prior to a flush cycle. An inlet is located in the passageway downstream from the dam to introduce water into the passageway downstream from the dam. The valve is located between the inlet and the outlet of the passageway, and the valve retains a second volume of water when in a closed position prior to the flush cycle of the toilet to affect a siphon during the flush cycle.

Abstract: A siphonic toilet including a bowl, a passageway and a valve. The passageway includes an entrance fluidly connected to the bowl, an outlet, and a dam located between the entrance and the outlet, wherein the dam and bowl are configured to hold a first volume of water prior to a flush cycle. An inlet is located in the passageway downstream from the dam to introduce water into the passageway downstream from the dam. The valve is located between the inlet and the outlet of the passageway, and the valve retains a second volume of water when in a closed position prior to the flush cycle of the toilet to affect a siphon during the flush cycle.

Abstract: The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Abstract: The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Abstract: The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Abstract: The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible three-dimensional surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Abstract: The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible three-dimensional surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Abstract: The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Abstract: The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible three-dimensional surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Abstract: The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible three-dimensional surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Abstract: The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Abstract: The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible three-dimensional surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Abstract: The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible three-dimensional surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Abstract: The present invention is directed to a method of producing compositions including embryonic proteins. The method includes culturing cells under hypoxic conditions on a biocompatible three-dimensional surface in vitro. The culturing method produces both soluble and non-soluble fractions, which may be used separately or in combination to obtain physiologically acceptable compositions useful in a variety of medical and therapeutic applications.

Abstract: An endourethral device including proximal and distal anchor assemblies selectively spaced apart by a device body is provided. The proximal anchor assembly is adapted to abuttingly engage at least portions of a bladder neck so as to at least proximally anchor said device, the distal anchor assembly being adapted to engage at least portions of a bulbous urethra so as to at least distally anchor said device. The body extends between the proximal and distal anchors assemblies, the device being adapted such that the anchors are selectively spaced apart for fixed positioning within a lower urinary tract in furtherance of a portion of the body at least partially traversing a prostatic urethra.

Abstract: An endourethral device including proximal and distal anchor assemblies selectively spaced apart by a device body is provided. The proximal anchor assembly is adapted to abuttingly engage at least portions of a bladder neck so as to at least proximally anchor said device, the distal anchor assembly being adapted to engage at least portions of a bulbous urethra so as to at least distally anchor said device. The body extends between the proximal and distal anchors assemblies, the device being adapted such that the anchors are selectively spaced apart for fixed positioning within a lower urinary tract in furtherance of a portion of the body at least partially traversing a prostatic urethra.

Abstract: A tissue culture chamber is disclosed. The chamber is a casing that provides for growth of three-dimensional tissue, and more specifically for the growth of skin tissue, that can be grown, preserved in frozen form, and shipped to the end user in the same aseptic container. The tissue culture chamber includes a casing comprising a substrate within the casing designed to facilitate three-dimensional tissue growth on the surface of the substrate. The casing includes an inlet and an outlet port which assist the inflow and outflow of media. The casing also includes at least one flow distributor. In one embodiment, the flow distributor is a baffle, which is used to distribute the flow of the media within the chamber to create a continuous, uniform piece of three-dimensional tissue. In a second embodiment, the flow distributor is a combination of deflector plates, distribution channels, and a flow channel.

Abstract: An apparatus for the large scale culturing and packaging of cell suspensions, three dimensional tissue, and other biological systems is disclosed. The apparatus includes a plurality of flexible or semi-flexible treatment chambers comprising one or more individual culture pockets, a plurality of rigid spacers, an inlet fluid manifold, an outlet fluid manifold, a fluid reservoir, and a means for transporting fluid within the system. During treatment, liquid media is transported from the fluid reservoir to the inlet manifold, which will in turn evenly distribute the media to each of the connected treatment chambers and internal culture pockets. An outlet fluid manifold is also provided to ensure that each treatment chamber is evenly filled and to ensure that any air bubbles formed during treatment are removed from the treatment chambers. The treatment chambers are flexible or semi-flexible so as to provide for easy end-user handling during rinsing and application of the cultured transplants.

Abstract: An underground storage tank provided with a manway is equipped with a riser extending from the storage tank, about the manway, to a point just below the access way provided in the ground level of the installation. The riser is provided with a water-tight cover which is released through operation of a cam. The water-tight riser excludes water from the interior of the riser and the manway, ensuring access to the manway, operation of the fittings provided in the manway, an additional containment of fluid passing through the manway and the area of the tank adjacent thereto. Because it is water-tight, an alarm sensitive to liquid may be placed in the interior of the riser to alert the operator to the possible loss of containment, or loss of water-tight sealing between the cover and the riser.